Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma
Daniel A. Rauch(Washington University in St. Louis), Hua Pan(University of South Florida)
Cited by 12
Related Papers
Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade
|Blood|2019|106
Anti-JNK2 peptide–siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice
|International Journal of Nanomedicine|2018|30
An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia
|Journal of Biological Chemistry|2018|27
Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma
|Retrovirology|2020|16